Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 226-956-0 | CAS number: 5578-42-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 9-Apr-1987 to 21-Aug-1987
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- The restrictions were that the number of erythrocytes scored for the detection of micronucleus was not in accordance with the current guideline and the administered dose exceeded the recommended limit dose for this assay.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- (old guideline)
- Deviations:
- yes
- Remarks:
- : only 1000 PCE's per animal examined instead of the 2000 required by current regulation.
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Cyclohexylmethyldimethoxysilane
- IUPAC Name:
- Cyclohexylmethyldimethoxysilane
- Reference substance name:
- Cyclohexyldimethoxymethylsilane
- EC Number:
- 402-140-1
- EC Name:
- Cyclohexyldimethoxymethylsilane
- Cas Number:
- 17865-32-6
- Molecular formula:
- C9H20O2Si
- IUPAC Name:
- Cyclohexyl-dimethoxy-methylsilane
Constituent 1
Constituent 2
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source:Charles River Italia S.p.A., Calco, Italy
- Weight at study initiation: 28-37g (males), 24-33g (females)
- Assigned to test groups randomly: no data
- Fasting period before study: overnight
- Acclimation period: 5 days
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Duration of treatment / exposure:
- Single exposure.
- Frequency of treatment:
- Single administration.
- Post exposure period:
- Animals were sacrificed at 24, 48 and 72 hours after treatment.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 10 other: mL/kg (nominal)
- Remarks:
- vehicle
- Dose / conc.:
- 2 500 mg/kg bw/day (nominal)
- Remarks:
- test material
- Dose / conc.:
- 5 000 mg/kg bw/day (nominal)
- Remarks:
- test material
- Dose / conc.:
- 5 mg/kg bw/day (nominal)
- Remarks:
- Mitomycin C
- No. of animals per sex per dose:
- 5 male, 5 female
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Mitomycin C in sterile distilled water was prepared immediately prior to dosing.
Examinations
- Tissues and cell types examined:
- After sacrifice, the femurs were removed and marrow cells obtained by flushing with foetal calf serum.
- Details of tissue and slide preparation:
- TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): 24, 48, 72 hours
DETAILS OF SLIDE PREPARATION: The removed marrow cells obtained by flushing with foetal calf serum were centrifuged and a concentrated suspension prepared to make smears on slides. These slides were air - dried overnight and then stained with May-Gruenwald and Giemsa, and mounted with Eukitt. Three slides were made from each animal.
METHOD OF ANALYSIS: The slides were examined under medium magnification and one slide from each animal was selected according to staining and quality of smears. Where the toxicity of the test substance was not so great as to inhibit cell proliferation, at least 1000 PCEs were examined at high magnification (x1000) for the presence or absence of micronuclei. At the same time the number of normochromatic erythrocytes was also recorded. - Statistics:
- The incidence of micronucleated cells per 1000 erythrocytes (mature or polychromatic) are given as group means by sex, and for the sexes combined. The standard error of the means and rages are also shown. The animals presenting less than 200 PCEs per 1000 NCEs scored were excluded from the calculations and subsequent statistical analyses.
Results and discussion
Test resultsopen allclose all
- Key result
- Sex:
- male
- Genotoxicity:
- positive
- Remarks:
- at 48 hours increase in micronucleated PCEs at high dose level.
- Toxicity:
- yes
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Key result
- Sex:
- female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
In preliminary toxicity trials it was established that treatment with Cyclo-hexyl-dimethoxy-silane at 5000 mg/kg by oral gavage did not result in excessive lethality, and accordingly dose-levels of 5000 and 2500 mg/kg were selected for this study. The oral route of administration was used in this study on the instruction of the Sponsor.
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay):
- Ratio of PCE/NCE (for Micronucleus assay): A dose related increase in the ration of mature to polychromatic erythrocytes was observed at the 48 hour sampling time in the test substance treatment groups. Similar increases were observed at the 24 hour sampling time. This indicates that the treatment with the test substance exerted an inhibitory effect on cell division of bone marrow erythropoietic cells. The ratio of mature to polychromatic erythrocytes increased at all sampling times following treatment with the positive control compound., indicating that this treatment resulted in inhibition of the cell division of the bone marrow erythropoietic cells.
Any other information on results incl. tables
Table 1:Results of in vivo micronucleustest at 24 hours (both sexes combined)
|
Positive control 5 mg/kg |
0 mg/kg |
2500 mg/kg |
5000 mg/kg |
|
Number of cells evaluated |
1000 |
1000 |
1000 |
1000 |
|
Number of erythro-cytes |
normochromatic |
12675 |
11579 |
13891 |
12003 |
polychromatic |
9449 |
10070 |
9464 |
8948 |
|
polychromatic with micronuclei |
23.1 ± 2.9 |
1.4±0.5 |
1.6± 0.5 |
1.9±0.6 |
|
Ratio of erythrocytes |
polychromatic / normochromatic |
1.39 |
1.15 |
1.52 |
1.45 |
Table 2:Results of in vivo micronucleus test at 48 hours (females)
|
Positive control 5 mg/kg |
0 mg/kg |
2500 mg/kg |
5000 mg/kg |
|
Number of cells evaluated |
1000 |
1000 |
1000 |
1000 |
|
Number of erythro-cytes |
normochromatic |
5219 |
3467 |
7110 |
7206 |
polychromatic |
3080 |
5062 |
4426 |
3770 |
|
polychromatic with micronuclei |
11.3±3.5 |
1.4±0.7 |
2.3±0.8 |
1.8±1 |
|
Ratio of erythrocytes |
polychromatic / normochromatic |
2.12 |
0.69 |
1.69 |
2.2 |
Table 3:Results of in vivo micronucleus test at 48 hours (males)
|
Positive control 5 mg/kg |
0 mg/kg |
2500 mg/kg |
5000 mg/kg |
|
Number of cells evaluated |
1000 |
1000 |
1000 |
1000 |
|
Number of erythro-cytes |
normochromatic |
3632 |
5609 |
4450 |
5387 |
polychromatic |
1610 |
5000 |
4013 |
3600 |
|
polychromatic with micronuclei |
16.1±1.3 |
1.6±0.6 |
1.5±0.6 |
5.6±2.2 |
|
Ratio of erythrocytes |
polychromatic / normochromatic |
2.84 |
1.12 |
1.11 |
2.02 |
Table 4:Results of in vivo micronucleustest at 72 hours (both sexes combined)
|
Positive control 5 mg/kg |
0 mg/kg |
2500 mg/kg |
5000 mg/kg |
|
Number of cells evaluated |
1000 |
1000 |
1000 |
1000 |
|
Number of erythro-cytes |
normochromatic |
8856 |
9861 |
8041 |
8617 |
polychromatic |
5567 |
9016 |
9579 |
7000 |
|
polychromatic with micronuclei |
4±0.9 |
2±0.2 |
1.7±0.5 |
1.4±0.4 |
|
Ratio of erythrocytes |
polychromatic / normochromatic |
1.91 |
1.09 |
1.23 |
1.91 |
Applicant's summary and conclusion
- Conclusions:
- There was an increase in micronuclei 48 hours after dose administration, but only at a dose which exceeds the limit dose recommended for this assay, and only in male mice, not in female. No statistically significant increase was found when the results for male and female mice were combined. Considerable toxicity to bone marrow was observed and the number of polychromatic erythrocytes (PCEs) scored was only 3600 for the group, whereas it should have been 4000 per animal according to current guideline. The increase in micronuclei was observed in just one male animal (1000 cells scored for this animal). In view of the low number of cells scored, the negative result when results for male and female animals were combined, and the negative result from the in vivo rodent dominant lethal assay, indicating lack of cytogenicity in germ cells, the conclusion of negative for the in vivo micronucleus study is reasonable. The study was conducted in accordance to OECD 474 with deviations, and compliant with GLP..
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.